{"lastClose": 4.119999885559082, "len": 988, "date": "2023-03-07", "alpha_1": -0.7811565249964043, "beta_1": 0.853845370418066, "drawup_1": 0.7155424508464454, "natr_1": 20.40167243597932, "sup_1": -0.8236245658794917, "res_1": 0.707119819382104, "bullPattern_1": ["HIKKAKE"], "bearPattern_1": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU", "SEPARATINGLINES"], "rsi_1": 37.59589797874598, "adx_1": 18.501210348639024, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6469720432994396, "stratHoldAlpha_1": 250.45668623537298, "stratHoldDrawdown_1": -0.7388175647999213, "alpha_3mo": -0.3700901757652548, "beta_3mo": 1.6758917697253677, "drawup_3mo": 0.20805376931257258, "natr_3mo": 20.40167243597932, "sup_3mo": -0.10355989040152236, "res_3mo": 0.02103557922869504, "bullPattern_3mo": [], "bearPattern_3mo": ["3OUTSIDE", "CLOSINGMARUBOZU", "LONGLINE"], "rsi_3mo": 32.18883496556334, "adx_3mo": 37.11816126484264, "drawdown_3mo": -0.25899281871225666, "stratHoldSharpe_3mo": -1.8863472092938134, "stratHoldAlpha_3mo": 250.00637725332402, "stratHoldDrawdown_3mo": -0.23309353684103096, "Country": "United States", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Name": "NGM Biopharmaceuticals Inc.", "Market Cap": 336302955, "Sector": "Health Care", "IPO Year": 2019.0, "alpha%_1": 0.009724173271286725, "beta%_1": 0.40755844254312135, "drawup%_1": 0.669075932577794, "natr%_1": 0.9999999999989806, "drawdown%_1": 0.012657861949894026, "stratHoldSharpe%_1": 0.13541551633904453, "stratHoldAlpha%_1": 0.010460456550008204, "stratHoldDrawdown%_1": 0.01322733125062723, "alpha%_3mo": 0.1568063565459944, "beta%_3mo": 0.8985301248434688, "drawup%_3mo": 0.4003438030740702, "natr%_3mo": 0.9999999999972072, "drawdown%_3mo": 0.08136126795110132, "stratHoldSharpe%_3mo": 0.0746094003212017, "stratHoldAlpha%_3mo": 0.018307519163904284, "stratHoldDrawdown%_3mo": 0.08852267963624211}